Biomaterials and Biointerfaces Study Section – BMBI
The Biomaterials and Biointerfaces Study Section (BMBI) reviews applications concerned with biologically relevant research in materials science and the interaction of material surfaces with biological systems. Areas of interest include the theory, principles, design, and synthesis of biomaterials; the use of biomaterials in tissue engineering; characterization of new or existing biomaterials; and the interactions of biomaterials with proteins, membranes, cells, and tissues.
The List of Reviewers lists all present, whether standing members or temporary, to provide the full scope of expertise present on that date. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes.
Review Dates
Topics
- Biomaterial Design and Synthesis: Development and characterization of biomaterials; self-assembled materials; design principles, material processing, and combinatorial approaches to the synthesis of new biomaterials; biocompatibility, toxicity, structure/property relationships, and bio-durability.
- Tissue Engineering: New biomaterials and fabrication techniques for tissue engineering, transport and perfusion aspects of tissue engineering, and biomaterial scaffolds to support cells, stem cell differentiation and therapy, vascularization, implants/sensors, cellular regeneration, and wound healing for all tissues; interactions of biomaterials with cellular components.
- Molecular/Cellular Interfacial Interactions: Extracellular matrix; non-fouling and bioactive surfaces; improved understanding of the biology-biomaterials interface; biosurface characterization and technology; gene/drug delivery; patterning; surface characterization at the nano-scale.
Shared Interests and Overlaps
There are shared interests in bioengineering including biomaterials fabrication and optimization, tissue engineering, biomimetic culture systems, surface patterning and manipulation, implant biocompatibility, biosensors, MEMS and/or microfluidic devices, drug delivery systems with Bioengineering and Tissue Engineering for Neuroscience (BTEN). Applications that emphasize other tissue types are reviewed in BMBI. Applications that emphasize these areas working with neuroprosthetics, neural or ocular cells/tissues or in the contexts of nervous system function/repair are reviewed in BTEN.
There are shared interests with Bioengineering, Technology, and Surgical Sciences (BTSS). Applications that focus on basic aspects of tissue engineering, device compatibility, and sensors may be assigned to BMBI. Applications that focus on the translational and clinical development of tissue engineering, devices, and sensors may be assigned to BTSS.
There are shared interests with Cellular and Molecular Technologies (CMT). Applications more focused on the development and characterization of biomaterials and biomimetics may be assigned to BMBI. Applications involving the interaction of cells with biomaterials may be assigned to CMT if the focus is on the cellular and molecular processes. Engineered tissues and microphysiological systems having a significant biomaterial component may be assigned to BMBI, whereas three-dimensional cell culture platforms may be assigned to CMT. Applications proposing the manipulation of cells may be assigned to CMT if the focus is on the cellular response, whereas BMBI may be more appropriate for applications focused on the biomaterial/ECM interactions.
There are shared interests with Instrumentation and Systems Development (ISD). Applications that focus on device biocompatibility or novel cell culture platforms may be assigned to BMBI. Applications that focus more on device development may be assigned to ISD.
There are shared interests with Musculoskeletal Tissue Engineering (MTE) in the area of biomaterial development. Applications that focus on the design and development of new biomaterials/scaffolds for tissue engineering or wound healing may be assigned to BMBI. Applications that focus on musculoskeletal tissue engineering aspects may be assigned to MTE.
There are shared interests in gene and drug delivery with Drug and Biologic Therapeutic Delivery (DBTD). Applications that focus on biocompatibility of delivery vehicles or delivery from implants are reviewed in BMBI. Applications that focus more on the design and development of novel delivery vehicles, vectors, or payloads are reviewed in DBTD.
There are shared interests in nanobiomaterials with Innovations in Nanosystems and Nanotechnology (INN). Applications that address the use of nanomaterial-based approaches for tissue engineering are reviewed in BMBI. Applications that focus on the biocompatibility and toxicities associated with nanomaterials are reviewed in INN.
There are shared interests with Pulmonary Injury, Repair, and Remodeling (PIRR). Applications focused on lung tissue engineering that involve validation of bioengineering strategies for lung repair and regeneration may be reviewed in PIRR. Applications involving early stages of development of these strategies and technologies may be reviewed in BMBI.
